Question Bank › Disproportional response

Disproportional response

Disproportional response: a small company's current business is visibly outgrowing its own size

Calls Tested
491
Answered YES
4
Hit Rate
0.8%
rare by design

Montrose Environmental Group, Inc. (MEG) — this company's answers

NO on the Q3 2023 call 2023-11-08 C+
The model's full reasoning — Q3 2023 call → NO我们根据提供的财报电话会议记录来判断。管理层是否传达出公司当前业务活动相对于公司规模而言是“不成比例地大”的?即公司还小,但正在发生的事情很大。 在记录中,管理层多次提到“record results”、“strong organic growth”、“exceptional performance”,但这些都是常规的强劲表现描述。他们提到“regulatory tailwinds”、“macro tailwinds”,但这些都是行业趋势。他们提到收购,但那是扩张。 关键点:是否有管理层明确表示当前业务量相对于公司规模是巨大的?例如,提到单个客户或合同规模超过公司收入很大比例?或者提到公司正在处理超出其规模的项目? 在记录中,管理层提到CTEH业务“above run rate level”,但这是指该业务表现好,并非说它相对于公司规模巨大。他们提到“we are achieving both goals”关于调整后EBITDA目标,但那是内部目标。 没有看到管理层明确说“我们公司还小,但我们现在接到的业务量非常大,以至于我们的结果只是冰山一角”之类的表述。他们只是说业务增长强劲,但这是常规的。 因此,答案应为NO。

← Back to the full MEG analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup — that is, does management describe current activity, demand, or commitments arriving at a scale that is large relative to how small the company still is, so that the reported results look like the early portion of something meaningfully bigger rather than a full picture of the business? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation: the company is small, and what is happening to it now is disproportionately large compared with that smallness. Any genuine expression of this counts, and the form varies widely across industries. For example — management noting that the business it is winning, booking, or being asked to do is large next to the company's current revenue, footprint, or headcount; that a single customer, contract, program, product, or market now in motion could by itself rival or exceed a meaningful share of today's company; that the company is handling, preparing for, or committing to volumes, projects, or relationships that would have been out of reach for a company of its size until now; that the same absolute wins keep translating into outsized percentage change because the base is still small; or management explicitly contrasting how little the company has captured so far with the scale of what is already reaching it. What matters is the DISPROPORTION, stated or plainly implied by management itself, between the size of the company and the size of what is currently arriving or being committed to it — grounded in real, present-tense business (orders, customers, work, volumes, commitments, or activity happening now), not in market-size statistics, pipelines, or hopes. Answer NO if the company is large relative to what it describes, or already a leading participant with no meaningful disproportion ahead of it. NO if management simply reports strong demand, a good quarter, or healthy growth in the ordinary way without conveying that what is arriving is large relative to the company's own small size. NO if the 'big opportunity' language is a generic total-addressable-market figure, an industry forecast, or promotional talk about a huge market with no reference to how little of it this company has taken or how small the company is against what is already reaching it. NO if the large-scale business described is only prospective — a market not yet entered, an approval or decision still pending, a customer still being pursued, a product still being developed — rather than something already arriving or already committed. NO if the disproportion is described only as a dependency risk or concentration concern management is trying to reduce. NO if the idea appears only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D

How the model reasoned

VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.

More from the question bank

Operating in the future tenseBreak from their own historyThe open question just closedQ&A has flipped from problems to possibilitiSold before it existsCheap-to-serve incremental businessAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.